{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-035584","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2021-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.966904+00:00","generated_at":"2026-06-30T07:31:43.793992+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Eledon appoints Jan Hillson, M.D. as independent director; grants option for 40,000 shares","bullets":["Jan Hillson, M.D. appointed to Eledon board effective July 1, 2021; qualifies as independent under Nasdaq rules.","Received option to buy 40,000 shares at $7.68 per share; vests 20,000 on first anniversary, 20,000 on second anniversary.","Dr. Hillson will enter Eledon's standard indemnification agreement; no family relationships with officers/directors.","No arrangements or understandings with any other person regarding her appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-035584","json":"https://secwatch.observer/filing/0001564590-21-035584.json","markdown":"https://secwatch.observer/filing/0001564590-21-035584.md","text":"https://secwatch.observer/filing/0001564590-21-035584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021035584/0001564590-21-035584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021035584/eldn-8k_20210701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T07:31:43.793992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59fb19b5b6","claim":"Jan Hillson, M.D. was appointed as Director at Eledon Pharmaceuticals, Inc..","evidence_excerpt":"On July 1, 2021, Jan Hillson, M.D. was appointed to the board of directors (the “Board”) of Eledon Pharmaceuticals, Inc., (“Eledon”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1404281/000156459021035584/0001564590-21-035584-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}